G Medical Innovations Holdings Ltd
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of G Medical Innovations Holdings Ltd generated cash of -$18,479,000, which is less than the previous year. Cash used in financing activities reached the amount of $14,863,000 last year. Net change in cash is therefore -$5,739,000.
Cash Flow
| 2016 | 0 | 0 | 0 |
|---|---|---|---|
| 2017 | 0 | -1.50M | 23.12M |
| 2018 | -15.45M | -4.85M | 8.85M |
| 2019 | 0 | -429K | 4.10M |
| 2020 | -4.64M | -455K | 5.38M |
| 2021 | -11.49M | -17K | 17.26M |
| 2022 | -18.47M | -2.12M | 14.86M |
GMVDW Cash Flow Statement (2016 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 6.03M | 278K | 0 | 2.63M | 14.15M | 752K | 0 |
Operating activities | |||||||
Net income | -25.06M | -14.88M | -12.68M | 0 | -24.05M | 0 | 0 |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 1.21M | 1.36M | 1.41M | 0 | 3.70M | 0 | 0 |
Stock-based compensation expense | 12.48M | 648K | 2.87M | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 12.48M | 648K | 2.87M | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | -86K | 210K | -161K | 0 | 0 | 0 | 0 |
Inventories | -2.02M | -265K | 288K | 0 | 0 | 0 | 0 |
Accounts payable | 2.32M | -1.73M | 739K | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -18.47M | -11.49M | -4.64M | 0 | -15.45M | 0 | 0 |
Investing activities | |||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -2.12M | -550K | -507K | -429K | -2.36M | -1.49M | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | -1.92M | 8K | 0 |
Cash generated by investing activities | -2.12M | -17K | -455K | -429K | -4.85M | -1.50M | 0 |
Financing activities | |||||||
Common Stock Issued | 3.44M | 13.41M | 8.99M | 0 | 967K | 23.00M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -121K | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -1.98M | -4.97M | 0 | -1.59M | 0 | 0 |
Cash used in financing activities | 14.86M | 17.26M | 5.38M | 4.10M | 8.85M | 23.12M | 0 |
Net Change In Cash | -5.73M | 5.75M | 278K | 3.66M | -11.52M | 13.40M | 0 |
Cash at end of period | 295K | 6.03M | 278K | 6.29M | 2.63M | 14.15M | 0 |
| Data source | Data source |